Voyageur Pharmaceuticals ( (TSE:VM) ) has shared an announcement.
Voyageur Pharmaceuticals announced significant achievements for 2024 and strategic plans for 2025, including a Letter of Intent with a major multinational pharmaceutical company to improve production efficiencies in contrast media products, highlighting their ambition to expand into new markets. The company also strengthened its leadership team with key appointments, aiming to drive growth and innovation in the medical imaging field.
More about Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a company focusing on vertically integrating the medical imaging industry. They specialize in the production of barium and iodine-based contrast media products, aiming to enhance their market presence through strategic partnerships and a comprehensive product suite.
YTD Price Performance: -5.00%
Average Trading Volume: 19,045
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $14.55M
Learn more about VM stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com